Bioorganometallics: First examples of cyclometalated iridium(III) complexes containing di- and tripeptide ester ligands

The synthesis of bis-cyclometalated [Ir(ptpy)₂(gly-gly-OEt)] (2, ptpy = 2-(p-tolyl)pyridinato; gly-gly-OEt = glycylglycine ethyl ester) and [Ir(ptpy)₂(gly-gly-gly-OEt)] (3, gly-gly-gly-OEt = glycylglycylglycine ethyl ester) from the reaction of [{Ir(μ-Cl)(ptpy)₂}₂] (1) with the corresponding peptide ester hydrochlorides in the presence of NaOMe is described. The molecular structure of 2 was confirmed by a single-crystal X-ray diffraction study. The compound crystallized from dichloromethane/iso-hexane in the space group P2₁/a. In the crystal packing the molecules of 2 exhibit N–H?O hydrogen bonds to the neighbor molecules to form dimeric units. The absorption and emission spectra of 2 and 3 were recorded and exhibit these compounds as strong green-emitting complexes.     

Cyclometalated rhodium(III) and iridium(III) complexes containing amino acids as N,O-chelates

The synthesis of bis-cyclometalated aminocarboxylato complexes [M(α-aminocarboxylato)(ptpy)₂] (M = Rh, 3, 4, 5; M = Ir, 6, 7, 8), ptpy = 2-(p-tolyl)pyridinato; aminocarboxylato = glycinato, l-alaninato, l-prolinato) from [{M(μ-Cl)(ptpy)₂}₂] (M = Rh, 1; M = Ir, 2) is described. The molecular structure of [Ir(l-alaninato)(ptpy)₂] (7) was confirmed by a single-crystal X-ray diffraction study. Compound 7 crystallized from methanol-iso-hexane in the space group P2₁. For 7 the two diastereoisomers Δ_Ir, S_C and Λ_Ir, S_C were found crystallizing twice per unit. Absorption and emission spectra were recorded. The rhodium compounds are weak yellow-green and the iridium species strong green emitters.     

Synthesis, structures and properties of new cyclometalated iridium(III) complexes of 3-methoxy-6-methyl-2-(naphthalen-2-yl)pyridine

The reaction between 3-methoxy-6-methyl-2-(naphthalen-2-yl)pyridine 1 and IrCl₃ was performed in an attempt to synthesize a cyclometalated Ir(III) Cl-bridged dimer 2. An unexpected Ir(III) complex 3 was isolated, which was a five-coordinate bis-cyclometalated Ir(III) complex. The complexes 2 and 3 were converted to the same mononuclear complex 4 upon reacting with acetylacetonate (acac), respectively. All of the new compounds have been fully characterized by elemental analysis, IR, ¹H, ¹³C{¹H} NMR and ESI-MS. Additionally, the crystal structures and properties of these Ir(III) complexes are investigated. The most striking common features of the structures of 2 and 3 is intramolecular C-H···Cl hydrogen bonds. The complex 4 shows yellow phosphorescence with structureless emission peaks at about 556 nm.     

Interaction of free functional group with platinum(II) center in cyclometalated complexes: A structural and photophysical property investigation

A series of flexible multidentate ligands containing N,P-donor, 2-[N-(diphenylphosphino)methyl]amino-pyridine (L¹), 2-[N-bi-(diphenylphosphino) methyl]amino-pyridine (L²), 2-[N-(diphenylphosphino)methyl]amino-7-methyl-1,8-naphthyridine (L³) and 4-[(N-diphenylphosphino)methyl]amino-pyridine) (L⁴) have been synthesized. The mono- and dinuclear cyclometalated platinum(II) complexes [Pt(C^N^N)L¹]ClO₄ (HC^N^N = 6-phenyl-2,2′-bipyridine), [Pt₂(C^N^N)₂L¹](ClO₄)₂, [Pt₂(C^N^N)₂L²](ClO₄)₂, [Pt(C^N^N)L³]ClO₄ and [Pt₂(C^N^N)₂L⁴](ClO₄)₂ were prepared and their structures determined by X-ray crystal analysis. These complexes exhibit long-lived bright orange emissions ranging from 560 to 610 nm in the solid state at room temperature. In solution, dinuclear complexes have emissions with higher quantum yields than mononuclear complexes. This can be attributed to intramolecular interaction of free functional group with Pt(II) at axial position, resulting in the quenching of phosphorescence for platinum(II) complexes in the ³MLCT excited state.     

Multimetallic compounds containing cyclometalated Ir(III) units: Synthesis, structure, electrochemistry and photophysical properties

The reaction of the cyclometalated Ir^III dimer [{(ppy)₂Ir}₂(μ-Cl)₂] (ppyH = 2-phenylpyridine) with silver triflate followed by a multidentate ligand [1,4-bis[3-(2-pyridyl)pyrazolylmethyl]benzene (bppb), 1,3,5-tri[3-(2-pyridyl)pyrazolylmethyl]-2,4,6-trimethylbenzene (tppb), 2,4,6-tris(2-pyridyl)-1,3,5-triazine (tptz), 2-chloro-4,6-bis(dipyridin-2-ylamino)-1,3,5-triazine (cddt) or 2,4,6-tris(dipyridin-2-ylamino)-1,3,5-triazine (tdat)] afforded di- or trinuclear compounds: [{Ir(ppy)₂}₂(μ-bppb)](OTf)₂ (1), [{Ir(ppy)₂}₃(μ-tppb)](OTf)₃ (2), [{Ir(ppy)₂}₂(μ-tptz-OH)](OTf) (3), [{Ir(ppy)₂}₂(μ-cddt)](OTf)₂ (4) and [{Ir(ppy)₂}₂(μ-tdat)](OTf)₂ (5). All of these compounds contain cationic metal cores with corresponding triflate counter anions. The molecular structures of 1-4 reveal that the structural feature of the Ir(ppy)₂ center of the starting precursor is conserved in the products. Also, because of the nature of the ligands, there is virtually no electronic communication between the Ir^III centers except in 3 where a ring hydroxylation at the triazine carbon atom is effected upon metalation. Compounds 1-5 are robust in solution where they retain their structural integrity. The UV-Vis and emission spectra of 1-5 compounds are very similar to each other with the exception of 3 which seems to possess a different electronic structure. All the compounds are luminescent at room temperature. The emission bands indicate significant contribution from ³LC. Increase in the number of ‘Ir(ppy)₂’ units does not have any effect on emission color.     

Tuning of emission: Synthesis, structure and photophysical properties of imidazole, oxazole and thiazole-based iridium (III) complexes

Three new iridium (III) complexes with two cyclometalated C^∧N ligands (imidazole, oxazole and thiazole-based, respectively) and one acetylacetone (acac) ancillary ligand have been synthesized and fully characterized. The structure of the thiazole-based complex has been determined by single crystal X-ray diffraction analysis. The Ir center was located in a distorted octahedral environment by three chelating ligands with the N-N in the trans and C-C in the cis configuration. By changing the hetero-atom of C^∧N ligands the order S, O and N, a marked and systematic hypsochromic shift of the maximum emission peak of the complexes was realized. The imidazole-based complex emits at a wavelength of 500 nm, which is in the blue to green region. The tuning of emission wavelengths is consistent with the variation of the energy gap estimated from electrochemistry results. An electroluminescent device using the thiazole-based complex as a dopant in the emitting layer has been fabricated. A highly efficient yellow emission with a maximum luminous efficiency of 9.8 cd/A at a current density of 24.2 mA/cm² and a maximum brightness of 7985 cd/m² at 19.6 V has been achieved.     

Synthesis, structure, and photophysical properties of a bis-cyclometalated heteroleptic iridium(III) complex containing 2,2′-dipyridylamine

The synthesis, X-ray crystal structure and luminescence properties of a new bis-cyclometalated heteroleptic complex, [Ir(ppy)₂(HDPA)](PF₆) (1, ppy = 2-phenylpyridine, HDPA = 2,2′-dipyridylamine), are reported. Both at room temperature and 77 K, complex 1 exhibits intense blue emission, assigned as ³MLCT [dπ(Ir)-π^∗(HDPA)] phosphorescence. Analysis of voltammetric data also provides evidence in support of this assignment.     

Diphosphinoazine rhodium(III) and iridium(III) octahedral complexes

Rhodium(III) and iridium(III) octahedral complexes of general formula [MCl₃{R₂PCH₂C(Bu^t)NNC(Bu^t)CH₂PR₂}] (M = Rh, Ir; R = Ph, c-C₆H₁₁, Prⁱ, Bu^t; not all the combinations) were prepared either from the corresponding diphosphinoazines and RhCl₃ · 3H₂O or by the oxidation of previously reported bridging complexes [{MCl(1,2-η:5,6-η-CHCHCH₂CH₂CHCHCH₂CH₂)}₂{μ-R₂PCH₂C(Bu^t)NNC(Bu^t)CH₂PR₂}] with chlorine-containing solvents. Depending on the steric properties of the ligands, complexes with facial or meridional configuration were obtained. Crystal and molecular structures of three facial and two meridional complexes were determined by X-ray diffraction. Hemilability of ligand in the complex fac-[RhCl₃{(C₆H₁₁)₂PCH₂C(Bu^t)NNC(Bu^t)CH₂P(C₆H₁₁)₂}] consisting in reversible decoordination of the phosphine donor group in the six-membered ring was observed as the first step of isomerization between fac and mer isomers.     

The synthesis and reactivity of electrophilic iridium (III) complexes containing bis (diphenylphosphino) ethane

The complex Ir(CH₃) (CO) (CF₃SO₃)₂ (dppe) (1) has been synthesized from the reaction of Ir(CH₃)I₂(CO) (dppe) and silver triflate. Methane and IrH(CO) (CF₃SO₃)₂ (dppe) (2) are formed when a methylene chloride solution of 1 is placed under 760 torr dihydrogen. Conductivity studies indicate that methylene chloride solutions of complexes 1 and 2 are weak electrolytes and only partially ionized at concentrations above 1 mM. Complex 2 is an effective hydrogenation catalyst for ethylene and 1-hexene while acetone hydrogenation is inhibited by the formation of [IrH₂(HOCH(CH₃)₂) (CO) (dppe)] (OTf) (3). Linear dimerization and polymerization of styrene occurs via a carbocationic mechanism initiated by triflic acid elimination from 2. Treatment of an acetonitrile solution of Ir(CH₃)I₂(CO) (dppe) with silver hexafluorophosphate produces the solvent promoted carbonyl insertion product [Ir(C(O)CH₃) (NCCH₃)₃ (dppe)] [PF₆]₂ (7) which readily undergoes deinsertion in methylene chloride to form [Ir(CH₃) (CO) (NCCH₃)₂ (dppe)] [PF₆]₂ (8) and acetonitrile.     

Synthesis, photophysical and electrochemical properties, and biological labelling studies of luminescent cyclometallated iridium(III) bipyridine-aldehyde complexes

We report the synthesis, characterisation, and photophysical and electrochemical properties of a series of luminescent cyclometallated iridium(III) bipyridine-aldehyde complexes [Ir(N-C)₂(bpy-CHO)](PF₆) (HN-C=2-phenylpyridine, Hppy (1); 2-(4-methylphenyl)pyridine, Hmppy (2); 1-phenylpyrazole, Hppz (3); 3-methyl-1-phenylpyrazole, Hmppz (4); 7,8-benzoquinoline, Hbzq (5); 2-phenylquinoline, Hpq (6); bpy-CHO=4-formyl-4^′-methyl-2,2^′-bipyridine). The X-ray crystal structures of complexes 1 and 4 have been determined. On the basis of the photophysical data, the emission of these complexes is assigned to an excited state of predominantly triplet metal-to-ligand charge-transfer (³MLCT) (dπ(Ir) → (bpy-CHO)) character. For complex 6, the excited state is also mixed with substantial (³IL) () (pq⁻) character. The protein bovine serum albumin has been labelled with these complexes to produce luminescent bioconjugates. The photophysical properties of the luminescent conjugates have also been investigated.     

Design and synthesis of a luminescent iridium complex-peptide hybrid (IPH) that detects cancer cells and induces their apoptosis

Tumor necrosis factor related apoptosis inducing ligand (TRAIL) triggers the cell-extrinsic apoptosis pathway by complexation with its signaling receptors such as death receptors (DR4 and DR5). TRAIL is a C₃-symmetric type II transmembrane protein, consists of three monomeric units. Cyclometalated iridium(III) complexes such as fac-Ir(tpy)₃ (tpy?=?2-(4-tolyl)pyridine) also possess a C₃-symmetric structure and are known to have excellent luminescence properties. In this study, we report on the design and synthesis of a C₃-symmetric and luminescent Ir complex-peptide hybrid (IPH), which contains a cyclic peptide that had been reported to bind to death receptor (DR5). The results of MTT assay of Jurkat, K562 and Molt-4 cells with IPH and co-staining experiments with IPH and an anti-DR5 antibody indicate that IPH binds to DR5 and induces apoptosis in a manner parallel to the DR5 expression level. Mechanistic studies of cell death suggest that apoptosis and necrosis-like cell death are differentiated by the position of the hydrophilic part that connects Ir complex and the peptide units. These findings suggest that IPHs could be a promising tool for controlling apoptosis and necrosis by activation of the extra-and intracellular cell death pathway and to develop new anticancer drugs that detect cancer cells and induce their cell death.     

Photochemical and photophysical properties of ruthenium(II) bis-bipyridine bis-nitrile complexes: Photolability

The electrochemical and photophysical properties of two bis-nitrilo ruthenium(II) complexes formulated as [Ru(bpy)₂(L)₂](PF₆)₂, where bpy is 2,2′-bipyridine and L is AN = CH₃CN and sn = NC-CH₂CH₂-CN, have been investigated. Electrochemical data are typical of Ru-bpy complexes with two reversible reduction peaks located near −1.3 and −1.6 V assigned to each bipyridine ligand and one Ru^II/Ru^III oxidation wave centered at approximately +1.5 V. The sn derivative is both IR and Raman active with its coordinated CN stretch appearing at 2277 cm⁻¹ and 2273 cm⁻¹, respectively. The UV/Vis absorption spectrum of the sn derivative is dominated by an intense (ε_max ∼ 58700 M⁻¹ cm⁻¹) absorption band at 287 nm assigned as a LC (π → π∗) transition. The peak observed at 418 nm (ε ∼ 10 400 M⁻¹ cm⁻¹) is an MLCT band while the one at 244 nm (ε ∼ 23 600 M⁻¹ cm⁻¹) is of LMLCT character. The AN derivative behaves similarly. Both complexes show low-temperature emission at around 537 nm with a lifetime near 10.0 μs. ¹H and ¹³C assignments are consistent with the formulation of the complexes. The complexes undergo photosubstitution of solvent with quantum efficiencies near one. Calculated and experimental results support replacement of the nitrile ligands by solvent. Based on DFT calculations, the electron density of the HOMO lies on the metal center, the bipyridine ligands and the nitrile ligands and electron density of the LUMO resides primarily on the bipyridine ligands. The electronic spectra obtained from TDDFT calculations closely match the experimental ones.     

The microwave synthesis of platinum(II) phosphine complexes

The microwave synthesis of a series of platinum(II) phosphine complexes is reported. The complexes dppePtCl₂ (dppe = bis(diphenylphosphino)ethane), dpppPtCl₂ (dppp = bis(diphenylphosphino)propane), dppmPtCl₂ (dppm = bis(diphenylphosphino)methane) and cis-(Ph₃P)₂PtCl₂ are synthesized from the reaction of potassium tetrachloroplatinate(II) and the phosphine. The isolated yields are 65% or better.     

Stereoselective synthesis of novel antiproliferative steroidal (E,E) dienamides through a cascade aldol/cyclization process

The stereoselective and metal-free protocol involving a cascade aldol/cyclization process for the synthesis of steroidal (E, E) dienamides from steroidal α, α-dicyanoalkene was reported. This protocol efficiently achieved the construction of CC bond and selective conversion of cyano group into carboxamide in one-pot procedure under mild condition. Further biological evaluation showed that some of these compounds had moderate to excellent cytotoxic activities against all the tested cancer cell lines and were more potent than well-known drug 5-fluorouracil. Particularly, compound 3c represented excellent inhibitory effect against MCF-7 (IC₅₀ = 0.76 μM), which was about 10-fold more potent than 5-fluorouracil.     

Stereoselective synthesis of N-galactofuranosyl amides

α- or β-Galactofuranosyl (Galf) amides can be synthesized with high stereoselectivity by traceless Staudinger ligation starting from unprotected β-galactofuranosyl azide or tetra-O-acetyl-β-galactofuranosyl azide, respectively. The resulting Galf amides are hitherto unknown molecules, with interesting potential as inhibitors of mycobacterial growth.     

Hydrido iridium(III) complexes of azoaromatic ligands. Isolation, structure and studies of their physicochemical properties

Reactions of 2-(arylazo)pyridine (L^a-c) with [IrCl₃(PPh₃)₂] in two different solvents, viz. ethanol and toluene are reported. In refluxing toluene two new isomeric (mer and fac geometries) iridium complexes, having molecular formula [IrCl₃(PPh₃)(L)] (1 and 2) have been isolated. The reaction in refluxing ethanol yielded two new hydrido complexes of molecular formula [IrHCl₂(PPh₃)(L)] (3) and [IrHCl(PPh₃)₂(L)]Cl (4) along with the compound 2. All the complexes have been thoroughly characterized by NMR, UV-Vis spectroscopy, cyclic voltammetry and X-ray crystallographic analysis. The ¹H NMR spectra of the hydrido complexes 3 and 4 showed a doublet and a triplet signals at δ −20.43 and −14.82 respectively due to coupling with magnetically equivalent phosphorous nuclei. Strong trans influence of the π-acceptor ligands guided the X-ray structural parameters; bonds trans to the these ligands are unusually long. Similar elongation effect was also noted for the bonds trans to the coordinated hydrido ligand. UV-Vis-NIR spectrum consisted of multiple transitions in the UV and visible regions. Cyclic voltammetry of each of these complexes has exhibited a reductive response between −0.25 and −0.55 V, which has been assigned to azo-ligand reduction. The compound 3, however, showed a quasireversible oxidative wave near 1.45 V, due to Ir^III/Ir^IV couple.     

Tuning iridium(III) complexes containing 2-benzo[b]thiophen-2-yl-pyridine based ligands in the red region

Synthesis and characterization of four iridium(III) complexes containing 2-benzo[b]thiophen-2-yl-pyridine based ligands are reported. The absorption, emission, electrochemistry, and thermostability of the complexes were systematically investigated. The (btmp)₂Ir(acac) (btmp = 2-benzo[b]thiophen-2-yl-4-methyl-pyridyl, acac = acetyl acetone) was characterized using X-ray crystallography. Calculation on the electronic ground state for (btmp)₂Ir(acac) was carried out using B3LYP density functional theory, HOMO levels are a mixture of Ir and btmp ligand orbitals, while the LUMO is predominantly btmp ligand based. Introduction of substituents (CH₃, CF₃) into pyridyl ring in a typical red emitter (btp)₂Ir(acac) leads to a marked decrease in the sublimation temperature, which is more suitable for OLEDs process. Electrochemical studies showed that (btmp)₂Ir(acac) has a slightly lower oxidation potential, but (btfmp)₂Ir(acac), (btfmp)₂Ir(dbm), and (btfmp)₂Ir(pic) (btfmp = 2-benzo[b]thiophen-2-yl-5-trifluoromethyl-pyridine, dbm = dibenzoylmethane, pic = 2-picolinic acid) containing CF₃ group are much difficult to oxidate than (btp)₂Ir(acac). The emission characteristics of these complexes can be tuned by either changing the substituents and their position on 2-benzo[b]thiophen-2-yl-pyridine or using different monoanionic ligands, showing emission λ_max values from 604 to 638 nm in CH₂Cl₂ solution at room temperature.     

Synthesis, spectroscopy, structure and photophysical properties of dinaphthylmethylarsine complexes of palladium(II) and platinum(II)

Dinaphthylmethylarsine complexes of palladium(II) and platinum(II) with the formulae [MX₂L₂] (M = Pd, Pt; L = di(1-naphthyl)methylarsine = Nap₂AsMe and X = Cl, Br, I), [M₂Cl₂(μ-Cl)₂L₂], [PdCl(S₂CNEt₂)L], [Pd₂Cl₂(μ-OAc)₂L₂] and [MCl₂(PR₃)L] (PR₃ = PEt₃, PPr₃, PBu₃, PMePh₂) have been prepared. These complexes have been characterized by elemental analyses, IR, Raman, NMR (¹H, ¹³C, ³¹P) and UV-vis spectroscopy. The stereochemistry of the complexes has been deduced from the spectroscopic data. The crystal structures of trans-[PdCl₂(PEt₃)(Nap₂AsMe)] and of [Pd(S₂CNEt₂)₂], a follow-up product, were determined. The UV-vis spectra of [MX₂L₂] complexes show a red shift on going from X = Cl to X = I. The complexes [PdX₂L₂] and [PtX₂L₂] are strongly luminescent in fluid solution and in the solid at ambient temperature.     

Ruthenium(III) maltolato-nitroimidazole complexes: synthesis and biological activity

The Ru(III) metronidazole-maltolato and -ethylmaltolato complexes, trans-[RuL₂(metro)₂]CF₃SO₃ (L = ma (1a) or etma (1b)), have been synthesized and tested for potential anti-tumour activity against the human breast cancer cell line MDA-MB-435S using a so-called MTT assay in phosphate-buffered saline; ma = 3-hydroxy-2-methylpyran-4-onato, etma = 2-ethyl-3-hydroxypyran-4-onato, metro = 2-methyl-5-nitro-1H-imidazole-1-ethanol (metronidazole); MTT = 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide. The complexes exhibit lower IC₅₀ values than our previously reported Ru(III) tris-maltolato and -ethylmaltolato complexes [D.C. Kennedy, A. Wu, B.O. Patrick, B.R. James, Inorg. Chem. 44 (2005) 6529–6535]. An improved synthetic route to the 2-nitroimidazole EF5 (2-(2-nitro-1-H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide) is reported, as well as a related synthesis of a 3-nitro-1,2,4-triazole derivative of EF5, triF5 (2-(3-nitro-1-H-triazol-1-yl)-N-(2,2,3,3,3- pentafluoropropyl)acetamide). The complexes [RuL₂(EF5)₂]CF₃SO₃ (4a and 4b) and [Ru(ma)₂(triF5)₂]CF₃SO₃ (5) were prepared from the [RuL₂(EtOH)₂]CF₃SO₃ complexes (3a and 3b); IC₅₀ values for 3–5 are high. Data on the uptake of Ru by the cells are also reported. The complexes were characterized generally by all or some of the following methods: elemental analyses, NMR, IR and mass spectroscopies, conductivity, and cyclic voltammetry; complexes 1a and 1b were also analyzed by X-ray crystallography.     

Syntheses and crystal structures of mononuclear and dinuclear (pentamethylcyclopentadienyl)iridium(III) complexes containing 2-mercaptobenzimidazole

A reaction of [Cp*IrCl₂]₂ {Cp* = η⁵-C₅(CH₃)₅} and 2-mercaptobenzimidazole (H₂bimt) in methanol in a 1:2 molar ratio gave a yellow complex of [Cp*IrCl₂(H₂bimt)]·CH₃OH (1). In compound 1 the H₂bimt acts as a monodentately S-donating (κS) ligand. A similar reaction of [Cp*IrCl₂]₂ and H₂bimt in the presence of NaOCH₃ (molar ratio of 1:2:2) gave an orange product (2) on addition of excess amount of NH₄PF₆. Compound 2 was composed of an unsymmetrical dinuclear complex cation, [(Cp*IrCl)₂(μ-Hbimt)(μ-H₂bimt)]⁺, a PF₆⁻ anion, and water molecules of crystallization. In the complex cation, H₂bimt bridges two Ir^III centers by S atom in the μ-κS:κS mode, while the monodeprotonated Hbimt⁻ ligand bridges via S and N atoms in the μ-κS:κN¹ mode.